Live Breaking News & Updates on Effectiveness Public Advisory Council

Drug's novel mechanism of action raises hopes of disease-modifying activity, but long-term cost-effectiveness rests on improvement in functional status. ....

United States , San Francisco , Greg Curfman , Marc Simon , Effectiveness Public Advisory Council , World Health Organization , Drug Administration , Midwest Institute For Clinical , University Of California , European Respiratory Society , Pulmonary Hypertension Center , Harvard Medical School , Journal Of The American Medical Association , European Society Of Cardiology , Midwest Institute , Economic Review , Comparative Effectiveness Public Advisory Council , American Medical , Pulmonary Arterial Hypertension , Ah Pulmonary Arterial Hypertension , Endothelin Receptor Antagonists , V Intravenous , Intravenous Route , Connective Tissue Disease , Heart Failure , Adverse Effects ,